Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Host intestinal epithelial cells (IECs) constitute a continuous single-cell layer that lines the gastrointestinal tract, serving as the primary interface between the host's internal environment and the external luminal contents [1]. These cells are essential for the selective absorption of nutrients, water, and electrolytes while simultaneously acting as a robust physical and immunological barrier against pathogens, toxins, and dietary antigens [2]. The epithelium is composed of several specialized lineages, including absorptive enterocytes, mucus-producing goblet cells, antimicrobial-secreting Paneth cells, and hormone-secreting enteroendocrine cells, all of which coordinate to maintain gut homeostasis [1][4]. In pathological conditions such as inflammatory bowel disease (IBD) or enteric infections, the disruption of IEC integrity leads to increased permeability and dysregulated immune signaling, contributing to chronic inflammation [3]. While IECs represent a heterogeneous cell population rather than a single molecular target, they express numerous specific receptors and transporters—such as Guanylate cyclase-C and various ion channels—that are targeted by pharmacological agents to treat gastrointestinal disorders [2][4]. Therapeutic interventions often aim to restore the epithelial barrier, modulate local secretory pathways, or utilize the high surface area of these cells for systemic drug delivery.
Drugs interacting with the intestinal epithelium typically function by activating specific apical receptors (e.g., Guanylate cyclase-C) to increase fluid secretion, providing local anti-inflammatory effects to maintain mucosal integrity, or stimulating epithelial proliferation and repair via growth factor pathways [1][4].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host intestinal epithelial cell (IEC).